CD4 and experimental autoimmune encephalomyelitis: We hypothesized that by exploiting the dependency of CD4+ T cells on extracellular Asn by systemically depleting Asn bioavailability, we could modulate the severity CD4+ T cell mediated pathologies, such as experimental autoimmune encephalomyelitis (EAE).